Helix BioPharma Corp. announced that Dr. Krzysztof Saczek has been appointed as a member of the Board of Directors of the Company effective immediately. Dr. Saczek is a Paediatric Surgeon, experienced in treating solid tumors, including malignancies in children. He has trained and practiced in several prominent medical centers in North America, Europe and South Africa. His area of expertise includes gastro-intestinal oncology.